<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26581994</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game.</ArticleTitle><Pagination><StartPage>1694</StartPage><EndPage>1704</EndPage><MedlinePgn>1694-704</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.01464-15</ELocationID><Abstract><AbstractText Label="UNLABELLED">Vaccine manufacturing costs prevent a significant portion of the world's population from accessing protection from vaccine-preventable diseases. To enhance vaccine production at reduced costs, a genome-wide RNA interference (RNAi) screen was performed to identify gene knockdown events that enhanced poliovirus replication. Primary screen hits were validated in a Vero vaccine manufacturing cell line using attenuated and wild-type poliovirus strains. Multiple single and dual gene silencing events increased poliovirus titers &gt;20-fold and &gt;50-fold, respectively. Host gene knockdown events did not affect virus antigenicity, and clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9-mediated knockout of the top candidates dramatically improved viral vaccine strain production. Interestingly, silencing of several genes that enhanced poliovirus replication also enhanced replication of enterovirus 71, a clinically relevant virus to which vaccines are being targeted. The discovery that host gene modulation can markedly increase virus vaccine production dramatically alters mammalian cell-based vaccine manufacturing possibilities and should facilitate polio eradication using the inactivated poliovirus vaccine.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Using a genome-wide RNAi screen, a collection of host virus resistance genes was identified that, upon silencing, increased poliovirus and enterovirus 71 production by from 10-fold to &gt;50-fold in a Vero vaccine manufacturing cell line. This report provides novel insights into enterovirus-host interactions and describes an approach to developing the next generation of vaccine manufacturing through engineered vaccine cell lines. The results show that specific gene silencing and knockout events can enhance viral titers of both attenuated (Sabin strain) and wild-type polioviruses, a finding that should greatly facilitate global implementation of inactivated polio vaccine as well as further reduce costs for live-attenuated oral polio vaccines. This work describes a platform-enabling technology applicable to most vaccine-preventable diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016, American Society for Microbiology. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van der Sanden</LastName><ForeName>Sabine M G</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Weilin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dybdahl-Sissoko</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weldon</LastName><ForeName>William C</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Les P</ForeName><Initials>LP</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Cedric</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tompkins</LastName><ForeName>S Mark</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oberste</LastName><ForeName>M Steven</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA soberste@cdc.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karpilow</LastName><ForeName>Jon</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Proventus Bio, Athens, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tripp</LastName><ForeName>Ralph A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, Georgia, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D023321">Poliovirus Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D023321" MajorTopicYN="N">Poliovirus Vaccines</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013678" MajorTopicYN="N">Technology, Pharmaceutical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014776" MajorTopicYN="N">Virus Cultivation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>7</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26581994</ArticleId><ArticleId IdType="pmc">PMC4733985</ArticleId><ArticleId IdType="doi">10.1128/JVI.01464-15</ArticleId><ArticleId IdType="pii">JVI.01464-15</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chumakov KM, Norwood LP, Parker ML, Dragunsky EM, Ran YX, Levenbook IS. 1992. RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence. J Virol 66:966&#x2013;970.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC240798</ArticleId><ArticleId IdType="pubmed">1309923</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgescu MM, Balanant J, Macadam A, Otelea D, Combiescu M, Combiescu AA, Crainic R, Delpeyroux F. 1997. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis. J Virol 71:7758&#x2013;7768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192128</ArticleId><ArticleId IdType="pubmed">9311861</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. 2013. Polio eradication &amp; endgame strategic plan 2013&#x2013;2018. World Health Organization, Geneva, Switzerland.</Citation></Reference><Reference><Citation>Cardosa MJ, Perera D, Brown BA, Cheon D, Chan HM, Chan KP, Cho H, McMinn P. 2003. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacific region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis 9:461&#x2013;468. doi:10.3201/eid0904.020395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0904.020395</ArticleId><ArticleId IdType="pmc">PMC2957976</ArticleId><ArticleId IdType="pubmed">12702227</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY. 2008. Enterovirus 71 in Taiwan. Pediatr Neonatol 49:103&#x2013;112. doi:10.1016/S1875-9572(08)60023-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1875-9572(08)60023-6</ArticleId><ArticleId IdType="pubmed">19054914</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, Chang Z, Liu F, Fang VJ, Zheng Y, Cowling BJ, Varma JK, Farrar JJ, Leung GM, Yu H. 2014. Hand, foot, and mouth disease in China, 2008&#x2013;12: an epidemiological study. Lancet Infect Dis 14:308&#x2013;318. doi:10.1016/S1473-3099(13)70342-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(13)70342-6</ArticleId><ArticleId IdType="pmc">PMC4035015</ArticleId><ArticleId IdType="pubmed">24485991</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang ZL, Mao QY, Wang YP, Zhu FC, Li JX, Yao X, Gao F, Wu X, Xu M, Wang JZ. 2013. Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother 9:1701&#x2013;1705. doi:10.4161/hv.24949.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.24949</ArticleId><ArticleId IdType="pmc">PMC3906269</ArticleId><ArticleId IdType="pubmed">23744508</ArticleId></ArticleIdList></Reference><Reference><Citation>Montagnon BJ, Nicolas AJ, Fanget B, Peyron L. 1981. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation. Dev Biol Stand 47:151&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pubmed">6262146</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Oberste MS, Alexander JP Jr, Kennett ML, Pallansch MA. 1999. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol 73:9969&#x2013;9975.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Echeverri CJ, Perrimon N. 2006. High-throughput RNAi screening in cultured cells: a user's guide. Nat Rev Genet 7:373&#x2013;384. doi:10.1038/nrg1836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg1836</ArticleId><ArticleId IdType="pubmed">16607398</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin L, Stone JK, Andino R. 2005. Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J Virol 79:1027&#x2013;1035. doi:10.1128/JVI.79.2.1027-1035.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.2.1027-1035.2005</ArticleId><ArticleId IdType="pmc">PMC538575</ArticleId><ArticleId IdType="pubmed">15613331</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakre A, Andersen LE, Meliopoulos V, Coleman K, Yan X, Brooks P, Crabtree J, Tompkins SM, Tripp RA. 2013. Identification of host kinase genes required for influenza virus replication and the regulatory role of microRNAs. PLoS One 8:e66796. doi:10.1371/journal.pone.0066796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0066796</ArticleId><ArticleId IdType="pmc">PMC3689682</ArticleId><ArticleId IdType="pubmed">23805279</ArticleId></ArticleIdList></Reference><Reference><Citation>Karber G. 1931. Beitrag zur kollektiven behandlung pharmakologischer reihenversuce. Arch Exp Pathol Pharmakol 162:480&#x2013;483. doi:10.1007/BF01863914.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01863914</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x2212;&#x394;&#x394;CT method. Methods 25:402&#x2013;408. doi:10.1006/meth.2001.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Meliopoulos VA, Andersen LE, Brooks P, Yan X, Bakre A, Coleman JK, Tompkins SM, Tripp RA. 2012. MicroRNA regulation of human protease genes essential for influenza virus replication. PLoS One 7:e37169. doi:10.1371/journal.pone.0037169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037169</ArticleId><ArticleId IdType="pmc">PMC3351457</ArticleId><ArticleId IdType="pubmed">22606348</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LF, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder L, Greene WC. 2005. NF-&#x3ba;B RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 25:7966&#x2013;7975. doi:10.1128/MCB.25.18.7966-7975.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.25.18.7966-7975.2005</ArticleId><ArticleId IdType="pmc">PMC1234328</ArticleId><ArticleId IdType="pubmed">16135789</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittmer J. 2003. The biology of the Ets1 proto-oncogene. Mol Cancer 2:29. doi:10.1186/1476-4598-2-29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-4598-2-29</ArticleId><ArticleId IdType="pmc">PMC194255</ArticleId><ArticleId IdType="pubmed">12971829</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Pan Y, Wang X, Lu J, Huang B, Li X. 2010. Activation of RASSF2A by p300 induces late apoptosis through histone hyperacetylation. Cell Biol Int 34:1133&#x2013;1139. doi:10.1042/CBI20090388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CBI20090388</ArticleId><ArticleId IdType="pubmed">20716062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z, Zhou L, Killela P, Rasheed AB, Di C, Poe WE, McLendon RE, Bigner DD, Nicchitta C, Yan H. 2009. Glioblastoma proto-oncogene SEC61&#x3b3; is required for tumor cell survival and response to endoplasmic reticulum stress. Cancer Res 69:9105&#x2013;9111. doi:10.1158/0008-5472.CAN-09-2775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-09-2775</ArticleId><ArticleId IdType="pmc">PMC2789175</ArticleId><ArticleId IdType="pubmed">19920201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitagawa M, Lee SH, McCormick F. 2008. Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Mol Cell 29:217&#x2013;231. doi:10.1016/j.molcel.2007.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2007.11.036</ArticleId><ArticleId IdType="pubmed">18243116</ArticleId></ArticleIdList></Reference><Reference><Citation>Macadam AJ, Ferguson G, Stone DM, Meredith J, Knowlson S, Auda G, Almond JW, Minor PD. 2006. Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication. J Virol 80:8653&#x2013;8663. doi:10.1128/JVI.00370-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00370-06</ArticleId><ArticleId IdType="pmc">PMC1563845</ArticleId><ArticleId IdType="pubmed">16912313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MS, Tseng FC, Wang JR, Chi CY, Chong P, Su IJ. 2012. Challenges to licensure of enterovirus 71 vaccines. PLoS Negl Trop Dis 6:e1737. doi:10.1371/journal.pntd.0001737.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001737</ArticleId><ArticleId IdType="pmc">PMC3429393</ArticleId><ArticleId IdType="pubmed">22953003</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedel CC, Haas J. 2011. Virus-host interactomes and global models of virus-infected cells. Trends Microbiol 19:501&#x2013;508. doi:10.1016/j.tim.2011.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2011.07.003</ArticleId><ArticleId IdType="pubmed">21855347</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin U, Nestler M, Munder T, Zell R, Sigusch HH, Henke A. 2004. Characterization of coxsackievirus B3-caused apoptosis under in vitro conditions. Med Microbiol Immunol 193:133&#x2013;139. doi:10.1007/s00430-003-0197-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-003-0197-7</ArticleId><ArticleId IdType="pubmed">13680215</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne CB, Bozym R, Morosky SA, Hanna SL, Mukherjee A, Tudor M, Kim KS, Cherry S. 2011. Comparative RNAi screening reveals host factors involved in enterovirus infection of polarized endothelial monolayers. Cell Host Microbe 9:70&#x2013;82. doi:10.1016/j.chom.2011.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2011.01.001</ArticleId><ArticleId IdType="pmc">PMC3048761</ArticleId><ArticleId IdType="pubmed">21238948</ArticleId></ArticleIdList></Reference><Reference><Citation>Yalamanchili P, Datta U, Dasgupta A. 1997. Inhibition of host cell transcription by poliovirus: cleavage of transcription factor CREB by poliovirus-encoded protease 3Cpro. J Virol 71:1220&#x2013;1226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191176</ArticleId><ArticleId IdType="pubmed">8995645</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavassoli P, Wafa LA, Cheng H, Zoubeidi A, Fazli L, Gleave M, Snoek R, Rennie PS. 2010. TAF1 differentially enhances androgen receptor transcriptional activity via its N-terminal kinase and ubiquitin-activating and -conjugating domains. Mol Endocrinol 24:696&#x2013;708. doi:10.1210/me.2009-0229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2009-0229</ArticleId><ArticleId IdType="pmc">PMC5417532</ArticleId><ArticleId IdType="pubmed">20181722</ArticleId></ArticleIdList></Reference><Reference><Citation>Fera D, Marmorstein R. 2012. Different regions of the HPV-E7 and Ad-E1A viral oncoproteins bind competitively but through distinct mechanisms to the CH1 transactivation domain of p300. Biochemistry 51:9524&#x2013;9534. doi:10.1021/bi3011863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi3011863</ArticleId><ArticleId IdType="pmc">PMC3521592</ArticleId><ArticleId IdType="pubmed">23121466</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakravarti D, Ogryzko V, Kao HY, Nash A, Chen H, Nakatani Y, Evans RM. 1999. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96:393&#x2013;403. doi:10.1016/S0092-8674(00)80552-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80552-8</ArticleId><ArticleId IdType="pubmed">10025405</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z, Centola M, Chen X, Sood R, Vedula A, Fischel-Ghodsian N, Kastner DL. 1998. Identification of two Kruppel-related zinc finger genes (ZNF200 and ZNF210) from human chromosome 16p13.3. Genomics 53:97&#x2013;103. doi:10.1006/geno.1998.5430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/geno.1998.5430</ArticleId><ArticleId IdType="pubmed">9787081</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida R, Ueki M, Yasuda T. 2012. Identification of Rhit as a novel transcriptional repressor of human Mpv17-like protein with a mitigating effect on mitochondrial dysfunction, and its transcriptional regulation by FOXD3 and GABP. Free Radic Biol Med 52:1413&#x2013;1422. doi:10.1016/j.freeradbiomed.2012.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2012.01.003</ArticleId><ArticleId IdType="pubmed">22306510</ArticleId></ArticleIdList></Reference><Reference><Citation>Wessels E, Duijsings D, Niu TK, Neumann S, Oorschot VM, de Lange F, Lanke KH, Klumperman J, Henke A, Jackson CL, Melchers WJ, van Kuppeveld FJ. 2006. A viral protein that blocks Arf1-mediated COP-I assembly by inhibiting the guanine nucleotide exchange factor GBF1. Dev Cell 11:191&#x2013;201. doi:10.1016/j.devcel.2006.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2006.06.005</ArticleId><ArticleId IdType="pubmed">16890159</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong AS, Wessels E, Dijkman HB, Galama JM, Melchers WJ, Willems PH, van Kuppeveld FJ. 2003. Determinants for membrane association and permeabilization of the coxsackievirus 2B protein and the identification of the Golgi complex as the target organelle. J Biol Chem 278:1012&#x2013;1021. doi:10.1074/jbc.M207745200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207745200</ArticleId><ArticleId IdType="pubmed">12244057</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor MP, Kirkegaard K. 2008. Potential subversion of autophagosomal pathway by picornaviruses. Autophagy 4:286&#x2013;289. doi:10.4161/auto.5377.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.5377</ArticleId><ArticleId IdType="pubmed">18094610</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Schaar HM, van der Linden L, Lanke KH, Strating JR, Purstinger G, de Vries E, de Haan CA, Neyts J, van Kuppeveld FJ. 2012. Coxsackievirus mutants that can bypass host factor PI4KIII&#x3b2; and the need for high levels of PI4P lipids for replication. Cell Res 22:1576&#x2013;1592. doi:10.1038/cr.2012.129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2012.129</ArticleId><ArticleId IdType="pmc">PMC3494396</ArticleId><ArticleId IdType="pubmed">22945356</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M. 2014. Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure. Microbiol Immunol 58:239&#x2013;256. doi:10.1111/1348-0421.12144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1348-0421.12144</ArticleId><ArticleId IdType="pubmed">24527995</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstaub D, Gradi A, Bercovitch Z, Grosmann Z, Nophar Y, Luria S, Sonenberg N, Kahana C. 2000. Poliovirus 2A protease induces apoptotic cell death. Mol Cell Biol 20:1271&#x2013;1277. doi:10.1128/MCB.20.4.1271-1277.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.4.1271-1277.2000</ArticleId><ArticleId IdType="pmc">PMC85262</ArticleId><ArticleId IdType="pubmed">10648613</ArticleId></ArticleIdList></Reference><Reference><Citation>Desmyter J, Melnick JL, Rawls WE. 1968. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol 2:955&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC375423</ArticleId><ArticleId IdType="pubmed">4302013</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Langereis MA, Lork M, Nguyen M, Hato SV, Lanke K, Emdad L, Bhoopathi P, Fisher PB, Lloyd RE, van Kuppeveld FJ. 2014. Enterovirus 2Apro targets MDA5 and MAVS in infected cells. J Virol 88:3369&#x2013;3378. doi:10.1128/JVI.02712-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02712-13</ArticleId><ArticleId IdType="pmc">PMC3957915</ArticleId><ArticleId IdType="pubmed">24390337</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>